Envoy Medical, Inc. (COCH)
↓ Download CSV- Sector Manufacturing
- Fiscal year ends Dec 31
In fiscal 2025, Envoy Medical, Inc. reported revenue of $241.0K, up 7.1% from the prior year. The company ran a net loss, with a net margin of -9857.3%. It held $8.56M in total assets against $20.32M in total liabilities.
Key ratios (FY2025)
-9240.7%
Operating margin
-9857.3%
Net margin
+7.1%
Revenue growth (YoY)
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Revenue | $241.0K | $225.0K | $316.0K | $237.0K | — | — |
| Cost of Revenue | $874.0K | $742.0K | $789.0K | $498.0K | — | — |
| Operating Income | -$22.27M | -$19.26M | -$18.36M | -$8.71M | -$5.20M | — |
| Net Income | -$23.76M | -$20.80M | -$29.92M | -$15.92M | -$251.6K | — |
| EPS (Diluted) | $-1.23 | $-1.49 | $-2.54 | $-1.57 | — | — |
| Total Assets | $8.56M | $11.54M | $8.27M | $2.56M | $426.90M | $120.0K |
| Total Liabilities | $20.32M | $30.38M | $10.05M | $38.75M | $38.62M | $95.7K |
| Shareholders' Equity | -$12.16M | -$18.84M | -$1.78M | -$36.20M | -$44.96M | $24.3K |
| Cash & Equivalents | — | — | $4.22M | $183.0K | $149.8K | $25.0K |
| Operating Cash Flow | -$18.20M | -$17.95M | -$17.09M | -$8.80M | -$3.24M | — |
| Capital Expenditures | $179.0K | $980.0K | $153.0K | $218.0K | — | — |
| Shares Outstanding | 23.26M | 18.79M | 12.30M | 10.12M | — | — |